Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,194 INR | +2.50% | +5.18% | +5.27% |
02-02 | Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit | MT |
01-31 | Transcript : Ajanta Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024 |
Sales 2024 * | 42.01B 504M 40.33B | Sales 2025 * | 47.09B 565M 45.22B | Capitalization | 276B 3.31B 265B |
---|---|---|---|---|---|
Net income 2024 * | 8.08B 96.91M 7.76B | Net income 2025 * | 9.5B 114M 9.12B | EV / Sales 2024 * | 6.39 x |
Net cash position 2024 * | 7.97B 95.6M 7.65B | Net cash position 2025 * | 13.8B 166M 13.25B | EV / Sales 2025 * | 5.57 x |
P/E ratio 2024 * |
34.6
x | P/E ratio 2025 * |
29.2
x | Employees | 7,713 |
Yield 2024 * |
0.92% | Yield 2025 * |
0.76% | Free-Float | 50.31% |
Latest transcript on Ajanta Pharma Limited
1 day | +2.50% | ||
1 week | +5.18% | ||
Current month | -1.67% | ||
3 months | +0.39% | ||
6 months | +24.92% | ||
Current year | +5.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 31/12/98 | |
Chief Executive Officer | 52 | 31/12/95 | |
Director of Finance/CFO | 59 | 22/04/98 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 31/12/95 | |
Chairman | 77 | 30/12/79 | |
Director/Board Member | 78 | 19/10/08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +1.11% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2,194 | +2.50% | 205,252 |
25/04/24 | 2,140 | +0.29% | 35,470 |
24/04/24 | 2,134 | +0.16% | 69,788 |
23/04/24 | 2,130 | +1.86% | 98,235 |
22/04/24 | 2,091 | +0.29% | 138,405 |
Delayed Quote NSE India S.E., April 26, 2024 at 12:43 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.27% | 3.31B | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- AJANTPHARM Stock